4.6 (610) · $ 20.00 · In stock
COVID-19 vaccines and adverse events of special interest: A
Frequency of adverse events 5 .
Makoto Yoshida's research works Fukushima Medical University, Fukushima and other places
Kenzo TAKAHASHI, Professor, MD, MHS, PhD, Teikyo University, Tokyo, Graduate School of Public Health
Preventable Adverse Drug Reactions: A Focus on Drug Interactions
Frontiers International Consensus Based Review and
Frequencies for the top 10 reported (a) adverse drug reactions and
STIVARGA® (regorafenib) Safety Information
Emergency Hospitalizations for Adverse Drug Events in Older
Makoto Yoshida's research works Fukushima Medical University, Fukushima and other places
Tianchen ZHAO, Fukushima Medical University, Fukushima
Retrospective analysis of clinical trial safety data for
PDF] Primer on Disproportionality Analysis
Time course of adverse reactions. The frequency of adverse